TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire June 11, 1993
TCL Archive Two Groups Take Different Approaches To Toxicity Of Saltz Regimen In Studies June 29, 2001
